Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Temsirolimus plus cisplatin and gemcitabine for advanced cancers including urothelial carcinoma
2007-007615-82Phase 2Terminated
- Sponsor
- Cardiff University
- Start
- Sep 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of temsirolimus, cisplatin and gemcitabine in transitional cell carcinoma (TCC), renal pelvis cancer and advanced nonhematological malignancy, sponsored by Cardiff University. Started Sep 2011; status: terminated.
02
Drugs
temsirolimuscisplatingemcitabine
03
Conditions
transitional cell carcinoma (TCC)renal pelvis canceradvanced nonhematological malignancy
Beyond the preview
Go deeper on 2007-007615-82.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-007615-82.